Connect with us

latest

PM Modi interacts with vaccine manufacturers, urges them to scale up production capacity

Published

on

Prime Minister Narendra Modi on Tuesday interacted with vaccine manufacturers in the country via video conferencing and urged them to continuously scale up the production capacity to vaccinate people in the shortest possible time.

 

Also Read : Lockdown is last alternative: PM Modi

 

He applauded the vaccine manufacturers for their achievements and professionalism and said the biggest strength of country’s vaccine industry is its ‘Samarthya, Sansadhan and Seva Bhaav’ and these attributes makes them a vaccine leader in the world.

He said the government has now allowed the vaccination programme for every adult starting May 1 believing in the ability of the vaccine manufacturers.

According to a PMO release, he also appreciated the efforts and studies being conducted by scientists in development of new vaccines.

He said the government ensured that all the vaccine manufacturers not only get all possible help and logistic support, but also the process of vaccine approval is speedy and scientific. He also assured that all possible support and smooth approval process for the vaccine candidates which are currently under trial phase.
The Prime Minister credited the manufacturers for developing and manufacturing vaccines in record time. Noting that vaccines manufactured India are the cheapest, PM Modi said the world’s largest vaccine programme is underway in the country.

The Prime Minister said that throughout the process of developing and manufacturing vaccines, the country has constantly worked with the spirit of public-private partnership under the ‘Mission Covid Suraksha’ and created an end-to-end vaccine development ecosystem.

He said the health infrastructure of the country’s private sector has played a big role in the country’s fight against COVID-19 and in the coming days, the private sector will play an even more active role in the vaccination drive.

This will require better coordination between hospitals and industry, he said.
The release said that the vaccine manufacturers thanked the Prime Minister for the government’s decision of allowing vaccination for everyone above the age of 18 and various steps taken to give more incentives and flexibility.

They also appreciated the Prime Minister’s leadership for the support they have received from the Centre throughout the process of vaccine development and production. They also discussed their plans to ramp up production, upcoming vaccine candidates and research on the new variants.

latest

Heavy floods completely damage Doda-Khellani road

Published

on

By

Amid severe Thunderstorm alert in the UT of Jammu and Kashmir and UT of Ladakh. A major portion of the Doda-Khelani road got blocked due to heavy rainfall. Along with vehicles, ambulances got stuck on the road as well. The road has been temporarily blocked for traffic.

 

http:/

Continue Reading

COVID 19

COVID Vaccine for age group 2 to 18 years old: Details inside

Published

on

By

Bharat Biotech

COVID Vaccine. The Subject Expert Committee (SEC) under India’s drug regulator has given its nod to Bharat Biotech for conducting phase 2 and 3 clinical trials of its Covid-19 vaccine Covaxin on children aged between 2 to 18 years old. The  COVID vaccine trial is expected to be conducted on 525 subjects at various sites, including AIIMS-Delhi, AIIMS-Patna.

On Tuesday, the Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organization (CDSCO) considered Hyderabad-based Bharat Biotech’s application seeking permission to conduct the COVID vaccine clinical trials to evaluate the safety of Covaxin vaccine among children.

 

READ MORE :  Dr. Jitendra Singh calls for audit for PM care Ventilators in GMC

 

While talking to the media an official said “After detailed discussion, the committee recommended for the conduct of proposed phase 2nd/3rd clinical trial of the whole virion inactivated coronavirus vaccine in the 2 to 18 years age group subject to the condition that the firm should submit the interim safety data of phase 2 clinical trial along with DSMB recommendations to the CDSCO before proceeding to phase 3 part of the study.

Amish Mahajan
Content Writer
JK Media

Continue Reading

Jammu

Weather Update for Jammu and Kashmir: The next 48 hours will be intense

Published

on

By

weather update

Weather Update J&K , likely to experience rain and thunderstorm

Jammu&Kashmir including Ladakh, Gilgit, Baltistan, Muzaffarabad, Himachal Pradesh, Uttarakhand, north Rajasthan, Odisha and Telangana, likely to experience rain and thunderstorm beginning from Thursday forecasted the Meteorological Department.

 

READ MORE :  COVID Vaccine for age group 2 to 18 years old: Details inside

 

The situation will remain like this till Friday. As the country celebrates Eid tomorrow it can well be said that the universe splashed rains on celebrations as people are likely to stay indoors.

Continue Reading

Covid-19 Stats

12 May 2021, 4:47 AM (GMT)

Coronavirus Stats

23,588,999 Total Cases
256,940 Death Cases
19,611,259 Recovered Cases

Facebook

Latest Posts

Archieves

May 2021
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Trending